Search - tctmd.com

Displaying 1 - 20 of 1568

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2026

Caitlin E. Cox

April 01, 2026

News Conference News ACC 2026

Impella Support in High-Risk PCI Doesn’t Help, Might Harm: CHIP-BCIS3

Yael L. Maxwell

March 29, 2026

News Conference News ACC 2026

Mechanical Circulatory Support Doesn’t Reduce Infarct Size in STEMI

Michael O'Riordan

March 28, 2026

News Conference News ACC 2026

What’s Going to Be Hot at ACC 2026

Michael O'Riordan

March 20, 2026

News Conference News CRT 2026

DOBERMANN: Dobutamine and Tocilizumab Show Promise in Pre-Shock Patients

L.A. McKeown

March 09, 2026

News Daily News

Advanced HF in Finland: Costs, Survival Diverge for Elective vs Urgent LVAD

Caitlin E. Cox

March 06, 2026

News Conference News CRT 2026

CRT 2026: What to Expect in Washington, DC

L.A. McKeown

March 04, 2026

Presentation THT 2026

Cardiogenic Shock Working Group: Triumphs and Tribulations

Presenter: Rachna Kataria

March 04, 2026

Presentation THT 2026

The PleioFlow Transcather Valve-powered Flow Pump - Next-Generation ultra-low profile physiologic circulatory support for patients in early stage Cardiogenic Shock

Presenter: Theo Mastrokostopoulos

March 04, 2026

Presentation THT 2026

Clinical Feasibility Study of the Magenta Elevate™ percutaneous Left Ventricular Assist Device (pLVAD) System in Patients with Cardiogenic Shock (ELEVATE™ CS FIH)

Presenter: David Israeli

March 04, 2026

Presentation THT 2026

Hemodynamic-Guided V-A ECMO Management For Cardiogenic Shock: Insight From Initial Experience From TWEET-1 Prospective Registry (To Wean An Ecmo Trials)

Presenter: Sriram Nathan

March 04, 2026

Presentation THT 2026

The Effects Of Istaroxime In Patients With Acute Heart Failure (AHF) And Cardiogenic Shock (CS) – Combined Analysis Of 5 Phase 2 Placebo Controlled Clinical Trials

Presenter: Beth A. Davison

March 04, 2026

Presentation THT 2026

When One Cause Isn't Enough: A Case of Cardiogenic Shock from Multiple Pathologies

Presenter: Archanna Radakrishnan

March 04, 2026

Presentation THT 2026

First-in-Human Use of the Elevate™ Percutaneous Left Ventricular Assist Device in Cardiogenic Shock

Presenter: David Israeli

March 03, 2026

Presentation THT 2026

Psoas Muscle Recovery After LVAD Implantation is Associated with Decreased Risk of Heart Failure Readmission in Cardiogenic Shock Patients

Presenter: Robert Anthony Adamian

March 03, 2026

Presentation THT 2026

Baseline Characteristics and Outcomes in Patients Presenting with Cardiogenic Shock: A Single-Center Cohort Study

Presenter: Michael Daidone

March 03, 2026

Presentation THT 2026

Cardiogenic Shock with Cardiac Arrest: Does It Always Represent SCAI Stage E?

Presenter: Maya Guglin

March 03, 2026

Presentation THT 2026

Comorbidity Burden and 30-Day Readmission After Cardiogenic Shock: Predictive Limits of Established Indices

Presenter: Ronit Kar

March 03, 2026

Presentation THT 2026

Prognostic Utility of Serum Lactate Dynamics for In-Hospital Mortality in Cardiogenic Shock: A Single Hub Regional Center Analysis

Presenter: Raul R. Neri Bale

March 03, 2026

Presentation THT 2026

Novel Prediction Model for In-Hospital Mortality in Cardiogenic Shock Patients

Presenter: Michael Daidone

March 03, 2026

Advertisement

TCTMD’s Top 10 Most Popular Stories for March 2026

Impella Support in High-Risk PCI Doesn’t Help, Might Harm: CHIP-BCIS3

Mechanical Circulatory Support Doesn’t Reduce Infarct Size in STEMI

What’s Going to Be Hot at ACC 2026

DOBERMANN: Dobutamine and Tocilizumab Show Promise in Pre-Shock Patients

Advanced HF in Finland: Costs, Survival Diverge for Elective vs Urgent LVAD

CRT 2026: What to Expect in Washington, DC

Cardiogenic Shock Working Group: Triumphs and Tribulations

The PleioFlow Transcather Valve-powered Flow Pump - Next-Generation ultra-low profile physiologic circulatory support for patients in early stage Cardiogenic Shock

Clinical Feasibility Study of the Magenta Elevate™ percutaneous Left Ventricular Assist Device (pLVAD) System in Patients with Cardiogenic Shock (ELEVATE™ CS FIH)

Hemodynamic-Guided V-A ECMO Management For Cardiogenic Shock: Insight From Initial Experience From TWEET-1 Prospective Registry (To Wean An Ecmo Trials)

The Effects Of Istaroxime In Patients With Acute Heart Failure (AHF) And Cardiogenic Shock (CS) – Combined Analysis Of 5 Phase 2 Placebo Controlled Clinical Trials

When One Cause Isn't Enough: A Case of Cardiogenic Shock from Multiple Pathologies

First-in-Human Use of the Elevate™ Percutaneous Left Ventricular Assist Device in Cardiogenic Shock

Psoas Muscle Recovery After LVAD Implantation is Associated with Decreased Risk of Heart Failure Readmission in Cardiogenic Shock Patients

Baseline Characteristics and Outcomes in Patients Presenting with Cardiogenic Shock: A Single-Center Cohort Study

Cardiogenic Shock with Cardiac Arrest: Does It Always Represent SCAI Stage E?

Comorbidity Burden and 30-Day Readmission After Cardiogenic Shock: Predictive Limits of Established Indices

Prognostic Utility of Serum Lactate Dynamics for In-Hospital Mortality in Cardiogenic Shock: A Single Hub Regional Center Analysis

Novel Prediction Model for In-Hospital Mortality in Cardiogenic Shock Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content